Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression

Kevin Gaffney; Michael Weinberg; Maira Soto; Stan Louie; Kathleen Rodgers

doi:10.3324/haematol.2018.193771

Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression

Kevin Gaffney, Michael Weinberg, Maira Soto, Stan Louie, Kathleen Rodgers

Pharmacology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	e567-e570
Journal	Haematologica
Volume	103
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2018.193771
State	Published - Nov 30 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2018.193771

Cite this

@article{24a2ebc123f84c4eb65a9c8ee5fdeda1,

title = "Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression",

author = "Kevin Gaffney and Michael Weinberg and Maira Soto and Stan Louie and Kathleen Rodgers",

year = "2018",

month = nov,

day = "30",

doi = "10.3324/haematol.2018.193771",

language = "English (US)",

volume = "103",

pages = "e567--e570",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

TY - JOUR

T1 - Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression

AU - Gaffney, Kevin

AU - Weinberg, Michael

AU - Soto, Maira

AU - Louie, Stan

AU - Rodgers, Kathleen

PY - 2018/11/30

Y1 - 2018/11/30

UR - http://www.scopus.com/inward/record.url?scp=85060864156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060864156&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.193771

DO - 10.3324/haematol.2018.193771

M3 - Letter

C2 - 29976741

AN - SCOPUS:85060864156

VL - 103

SP - e567-e570

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 12

ER -

Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this